Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

Brenda W. Cooper, Tomas Radivoyevitch, Beth A. Overmoyer, Robert R. Shenk, Huong T. Pham, Judith R. Samuels, Margaret P. Parry, Paula Silverman

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences